BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Alzheon

Alzheon logo

Founded
2013
Geography
United States of America based
Funding
$37 M

Alzheon is committed to developing innovative medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. Our Alzheon’s drug development platform which comprises proprietary chemistries, robust clinical efficacy and safety datasets in patients and genetically-defined subpopulations, and the ability to optimize molecules to have the desired therapeutic attributes.

Technologies

Pharmaceutical and Drug Discovery  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet